These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 10437743)

  • 1. Emerging role of docetaxel (Taxotere) in advanced non-small cell lung cancer.
    Gandara DR; Edelman MJ; Lau D
    Semin Oncol; 1999 Jun; 26(3 Suppl 10):3-7. PubMed ID: 10437743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Summary of phase II data of docetaxel (Taxotere), an active agent in the first- and second-line treatment of advanced non-small cell lung cancer.
    Fossella FV; Lee JS; Berille J; Hong WK
    Semin Oncol; 1995 Apr; 22(2 Suppl 4):22-9. PubMed ID: 7740327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of docetaxel (Taxotere) as a single agent or in combination before local treatment of non-small cell lung cancer.
    Harper P
    Semin Oncol; 1997 Aug; 24(4 Suppl 14):S14-30-S14-32. PubMed ID: 9335522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docetaxel (Taxotere) as a single agent and in combination chemotherapy for the treatment of patients with advanced non-small cell lung cancer.
    Miller VA; Kris MG
    Semin Oncol; 2000 Apr; 27(2 Suppl 3):3-10. PubMed ID: 10810932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination treatment with docetaxel (Taxotere) and platinum compounds for non-small cell lung cancer.
    Mattson K; Saarinen A; Jekunen A
    Semin Oncol; 1997 Aug; 24(4 Suppl 14):S14-5-S14-8. PubMed ID: 9335516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of docetaxel (Taxotere)/cisplatin combination in non-small cell lung cancer.
    Le Chevalier T; Bérille J; Zalcberg JR; Millward MJ; Monnier A; Douillard JY; McKeage MJ; James R; Soulas F; Loret C; Bougon N; Bizzari JP
    Semin Oncol; 1999 Jun; 26(3 Suppl 11):13-8. PubMed ID: 10458205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of docetaxel (Taxotere) in the treatment of non-small cell lung cancer.
    Fossella FV
    Semin Oncol; 1999 Jun; 26(3 Suppl 11):4-8. PubMed ID: 10458203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docetaxel (Taxotere) and neoadjuvant chemotherapy for non-small cell lung cancer.
    Mattson K
    Semin Oncol; 1999 Jun; 26(3 Suppl 10):25-8. PubMed ID: 10437748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of docetaxel (Taxotere) in patients with advanced non-small cell lung cancer previously treated with platinum-containing chemotherapy regimens.
    Fossella FV; Rigas J
    Semin Oncol; 1999 Jun; 26(3 Suppl 11):9-12. PubMed ID: 10458204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docetaxel (Taxotere) and vinorelbine in the treatment of non-small cell lung cancer.
    Georgoulias V; Kourousis C; Androulakis N; Kakolyris S; Papadakis E; Bouros D; Apostolopoulou F; Georgopoulou T; Agelidou M; Souglakos J; Halkiadakis G; Hatzidaki D
    Semin Oncol; 1997 Aug; 24(4 Suppl 14):S14-9-S14-14. PubMed ID: 9335517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development of docetaxel (Taxotere) in non-small cell lung cancer--docetaxel in new combinations and new schedules: an overview of ongoing and future developments.
    Donnellan PP; Crown JP
    Semin Oncol; 1997 Aug; 24(4 Suppl 14):S14-18-S14-21. PubMed ID: 9335519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docetaxel (Taxotere) in combination with platinum-based regimens in non-small cell lung cancer: results and future developments.
    Belani CP
    Semin Oncol; 1999 Jun; 26(3 Suppl 10):15-8. PubMed ID: 10437746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docetaxel for locally advanced or metastatic non-small-cell lung cancer. Current data and future directions as front-line therapy.
    Khuri FR
    Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):53-62. PubMed ID: 12108898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docetaxel in the treatment of non-small cell lung cancer: review of single-agent trials.
    Fossella FV
    Semin Oncol; 1999 Oct; 26(5 Suppl 16):17-23; discussion 41-2. PubMed ID: 10585004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docetaxel (Taxotere) in combination: a step forward.
    Burris HA; Fields S; Peacock N
    Semin Oncol; 1995 Dec; 22(6 Suppl 13):35-40. PubMed ID: 8604452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docetaxel (Taxotere) in the treatment of non-small cell lung cancer (NSCLC)--is there a role for a new chemotherapy programme?
    Armand JP
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():223-30. PubMed ID: 10895158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docetaxel and granulocyte colony-stimulating factor in patients with advanced non-small-cell lung cancer previously treated with platinum-based chemotherapy: a multicenter phase II trial.
    Alexopoulos K; Kouroussis C; Androulakis N; Papadakis E; Vaslamatzis M; Kakolyris S; Samelis G; Patila E; Vossos A; Samantas E; Georgoulias V
    Cancer Chemother Pharmacol; 1999; 43(3):257-62. PubMed ID: 9923557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New options in the treatment of non-small cell lung cancer.
    Fossella F; Rigas JR; Belani CP
    Anticancer Drugs; 1999 Nov; 10 Suppl 1():S25-8. PubMed ID: 10630365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docetaxel in the management of advanced non-small cell lung cancer.
    Miller VA
    Semin Oncol; 1998 Jun; 25(3 Suppl 8):15-9. PubMed ID: 9704671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docetaxel: new indication. First-line treatment of non small-cell lung cancer: no advance.
    Prescrire Int; 2005 Feb; 14(75):16-8. PubMed ID: 15751170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.